Recovery and Pigment Safety in the 2026 Split-Face Acne Scar Trial: Questions People With Skin of Color Can Ask Before a Procedure

In the 2026 split-face trial, recovery was brief and pigment problems were uncommon and short-lived. People with skin of color can focus their consult on redness time, PIH rate by skin type, sun protection, and the provider's experience with darker skin. A split-face trial treats one cheek one way and the other cheek another way for direct comparison. This trial enrolled adults with Fitzpatrick types III-V and moderate-to-severe atrophic scars, meaning indented acne scars, and compared fractional microneedle radiofrequency plus transdermal poly-L-lactic acid on one cheek with radiofrequency plus sterile water on the other, according to Dermatology and Therapy in the split-face trial report.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

What happened on each cheek?
How did healing and pigment look after treatment?
Why ask more pointed questions with darker skin?
What should you ask at the consult?
Who should perform microneedling for scars?

What happened on each cheek?

Operators used a monopolar microneedle radiofrequency device at 2.5-mm depth to open tiny skin channels. They then spread 2.5 mL of poly-L-lactic acid suspension evenly over one facial half so the channels carried the drug without injection.

Poly-L-lactic acid is a collagen-stimulating material already used in aesthetic medicine. Here transdermal means it passes through the microchannels rather than through a needle injection. The other cheek received the same energy treatment plus sterile water as the control.

How did healing and pigment look after treatment?

Mild postinflammatory hyperpigmentation, or dark spots after inflammation, occurred in two participants and cleared within one month. Mild redness and acne flares were transient and self-limited over days to weeks.

That pattern is favorable, but it describes a small study with short follow-up. Redness lasting days, new breakouts, and a low short-term dark-spot rate match what patients can ask their clinic to quantify for their own skin type.

Why ask more pointed questions with darker skin?

Baseline pigment risk is higher after acne and procedures in darker Fitzpatrick types. Prior literature cited in 2026 coverage estimates up to 90% of darker-Fitzpatrick patients may develop postinflammatory hyperpigmentation after acne, plus greater keloid and melanocyte-reactivity concerns, as reported by Dermatology Times in summary of the laser trial.

A separate prospective three-site U.S. trial tested a 1550-nm nonablative laser with focal-point conical beams in 47 subjects ages 21-72 across types I-VI for acne scars. It reported prolonged hyperpigmentation in 2.1% of subjects, lower than 57.1% and 40.0% cited from older traditional 1550-nm reports, attributed to deeper energy convergence with less superficial heat.

What should you ask at the consult?

Bring the trial limits into the visit: small samples, short follow-up, and exclusion of type VI limit how far results extend to very deep skin tones. Ask for the clinic's own numbers by skin type, not only device averages.

How long should redness, swelling, and flaking last for my skin type?
What is your postinflammatory hyperpigmentation rate by Fitzpatrick type, and how do you treat it?
What sun-protection, retinoid pause, and follow-up schedule do you require?
How many patients with type IV-VI skin have you treated with this exact setting?

Who should perform microneedling for scars?

Choose a qualified health-care provider rather than a home or salon service. The FDA notes cleared devices treat facial acne scars in adults 22 and older, recommends treatment by a health-care provider, states no microneedling device is authorized for over-the-counter sale, and warns RF-microneedling can cause burns, scarring, and pigment change, according to News-Medical in FDA safety guidance.

Ask to see consent forms that list burns, scarring, and pigment change for radiofrequency microneedling. Confirm who will manage prolonged redness, dark spots, breakouts, or suspected burn if they occur.